Our Team of Experts

We are a driven team of specialists, committed to advancing research in Psychiatric and Neurological Disorders. Our team has experience across multiple sectors – pharmaceutical operations, research and development, intellectual property, marketing and finance – and is based in the UK, Europe and North America.

An Experienced Board...

Filipp_new

Filipp Korentsvit

Co-Founder & Chief Executive Officer
Filipp_new

Max Moldaschl

Co-Founder & Chief Financial Officer
Filipp_new

Daud Gutseriev

Co-Founder & Chief Operating Officer
Filipp_new

William Jarosz

Partner & Executive Chairman of the Board of Directors
Filipp_new

Professor Richard Barker

Partner & Senior Advisor - Head of Advisory Board
Filipp_new

Dr Ian Hudson

Partner & Senior Regulatory Advisor
Filipp_new

Professor Trevor Jones

Partner & Senior Regulatory and Clinical Advisor
Filipp_new

Filipp_new

...Backed By Solid Science

Grace_new

Dr Grace Blest-Hopley

Partner & Chief Scientific Officer
Grace_new

Dr Scott Woods, MD

Partner & Senior Psychiatric Advisor
Grace_new

Dr John Kane, MD

Partner & Senior Psychiatric Advisor
Grace_new

Professor Matthew Walker

Partner & Chief Sleep Officer
Grace_new

Dr Riccardo De Marco

Clinical Research Associate
Grace_new

Professor Gennady Shvarts

Medical Advisor

Our Partners

We are powered by a passionate team and partners - spanning prestigious learnings institutions, R&D companies, and clinical centres.

R&D

Universities

Clinical

We aim to achieve our goals with scientific rigour and an evidence-based approach, utilising the latest technologies that are emerging in the pharmaceutical sector in pre-clinical development, clinical validation, drug formulation and drug delivery mechanisms.

TEAM MEMBER DETAILS

Management & Board

Filipp Korentsvit

Co-Founder & Chief Executive Officer

  • Executive Director at Goldman Sachs
  • Founded a mining services company in Mongolia
  • Financial advisor to family office
  • Bachelors of Science in Economics and Statistics from the University College London

Max Moldaschl

Co-Founder & Chief Financial Officer

  • Director at Citigroup Global Markets
  • Senior Cross- Asset Strategist BNP Paribas Asset Management
  • Masters in Engineering degree with First Class Honours in the field of Aeronautical Engineering from Imperial College London

Daud Gutseriev

Co-Founder & Chief Operating Officer

  • Associate Director at VTB Capital - Infrastructure Capital & Project Financing
  • Bachelors of Science degree in the field of Management from University of Royal Holloway
  • Executive MBA from University of Oxford - Saïd Business School

William Jarosz

Partner & Executive Chairman of the Board of Directors

  • Accomplished business leader, with a background in finance and pharma
  • Executive Board Member of Satellos Bioscience and President of a Satellos subsidiary specialising in micellization
  • MA in Law and Diplomacy from Tufts University and a JD from Harvard Law School

Prof. Richard Barker

Partner & Senior Advisor - Head of Advisory Board

  • Prof. Richard Barker, BSc, MA, DPhil (Oxon), FRSM, HFBPS, OBE is a senior leader in the global life sciences sector
  • 30-year career in senior roles in biopharmaceuticals (Director General ABPI and NED Celgene), diagnostics (CEO Chiron) and medical informatics (Global GM of IBM Healthcare)
  • Oxford University Press books: ‘2030—the future of medicine’ and ‘Bioscience—lost in translation?’

Dr Ian Hudson

Partner & Senior Regulatory Advisor

  • Dr Ian Hudson, OBE, MD, FRCP, FFPM is a senior leader in the global pharmaceutical sector
  • Over 30 years experience in pharmaceutical development and regulation at a senior level
  • Posts at SmithKline Beecham, and MHRA (Director of Licensing, then CEO)
  • Various other NED, Advisory and consultancy roles

Prof. Trevor Jones

Partner & Senior Regulatory and Clinical Advisor

  • Prof. Trevor Jones, CBE FMedSci PhD DSc Hon FRCP FBPhS FRSM FRSC FLSW, is a senior leader in the global pharmaceutical sector
  • Multi-decade career in senior roles in various pharma companies, as well as several senior governmental commissioner roles
  • Until recently Chair of the European Medicinal Cannabis Association (EUMCA)
  • Visiting professor at The Institute of Pharmaceutical Science at KCL

Lead Academics

Dr Grace Blest-Hopley

Partner & Chief Scientific Officer

  • Doctor of neuroscience, with a keen interest in the field of mental health and plant science
  • Ph.D. in the actions and effects of cannabinoids at King’s College London
  • Research director for a military charity (psychedelics)
  • Serves as an infantry officer in the reserve British armed forces

Dr Scott Woods, MD

Partner & Senior Psychiatric Advisor

  • World renowned expert in clinical high risk for psychosis (CHR-P). Leader of PSYCHS, SIPS, and Mini-SIPS assessment instruments for CHR-P
  • Elizabeth Mears and House Jameson Professor of Psychiatry and in the Child Study Center at Yale University School of Medicine
  • Diplomate of the American Board of Psychiatry and Neurology

Dr John Kane, MD

Partner & Senior Psychiatric Advisor

  • World renowned psychiatrist. Served as chair of psychiatry at Zucker Hillside Hospital for 34 years and chair of psychiatry at the Zucker School of Medicine for 12 years
  • Professor of Psychiatry and Molecular Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
  • Diplomate of the American Board of Psychiatry and Neurology

Prof. Matthew Walker

Partner & Chief Sleep Officer

  • Professor of Neuroscience and Psychology at the University of California, Berkeley, and Founder of the Center for Human Sleep
  • Published over 100 scientific research studies and author of “Why We Sleep: Unlocking the Power of Sleep and Dreams”
  • Degree in neuroscience from Nottingham University. PhD in neurophysiology from the Medical Research Council. Professor of Psychiatry at Harvard

Dr Riccardo De Marco

Clinical Research Associate

  • Doctor of Neuroscience, specializing in biological psychiatry and drug development for mental health
  • Ph.D. focusing on the development of screening tools for antidepressants in a human model of inflammation-associated depression
  • Served as a Research Assistant at Brighton and Sussex Medical School's Neuroscience Department
  • Masters of Science degree in Neuroscience from the University of Trieste

Prof. Gennady Shvarts

Medical Advisor

  • Professor of pharmacology with 40+ years experience
  • Specialises in the development of medicines, screening methodologies and clinical studies
  • Various senior positions, most recently at Teva Pharmaceutical
  • 30 patents and two innovative drugs (Troventol & Methiapril)

CONTACT US

0203 693 3791
team@nwpharmatech.com


OUR HEADOFFICE

Beaufort Gardens
London SW3 1PW
United Kingdom